Keywords: Icagen, Pfizer, Takeiver rumors, Clinical trial, Sodium channel program, Pain drug

Icagen skyrockets on Pfizer takeover rumors

Article | 28 June 2011

Print This

USA based Icagen (Nasdaq: ICGN) saws its shares leap more than 130% in early trading on speculation the company was a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in